Basma Adeem Medical issues prospectus for Nomu IPO

25/12/2024 Argaam
Logo ofBasma Adeem Medical Co.

Logo of Basma Adeem Medical Co.


Basma Adeem Medical Co. issued today, Dec. 25, the prospectus to float four million shares on the Nomu-Parallel Market.

 

The offered shares represent 25% of the company's pre-IPO capital of SAR 16 million (divided into 16 million shares) at a nominal value of SAR 1 per share. These shares shall represent 20% of the company’s SAR 20 million post-IPO capital.

 

For More IPOs

 

The IPO, limited to qualified investors as per the Capital Market Authority’s (CMA) regulations, will run for six working days from Jan. 15-19, 2025.

 

In Oct. 28, the CMA approved the company's application to float its shares on Nomu.

 

Basma Adeem Medical was founded in 2012 and is based in Riyadh. It was incepted as a limited liability company before becoming a closed joint-stock Saudi company.

 

The company’s actual activity is dentistry, offering treatment and cosmetic services. Its commercial registration lists additional activities, including specialty medical complexes, day surgery centers, medical clinics, and managing the operations of these facilities.

 

Company Profile 

Company 

Basma Adeem Medical Co.

Market 

Nomu-Parallel Market

Core Activities 

Dental treatment & cosmetics

Pre-IPO Capital

SAR 16 mln

Current Number of Shares

16 mln

Post-IPO Capital

SAR 20 mln

New Number of Shares

20 mln

Par Value 

SAR 1 per share

 

IPO Summary

Issue Percentage

20% of post-increase capital (25% of pre-IPO capital)

Offered Shares

4 mln

IPO Minimum Limit

100 shares

IPO Maximum Limit

999,900 shares

Offer Period

Five working days from Jan. 13-19, 2025

Final Allocation

Jan. 22, 2025

Surplus Refund (If any)

Jan. 26, 2025

 

Company Shareholders

Shareholder

Pre-IPO

Post-IPO

Number of Shares

(‘000)

Ownership (%)

Number of Shares

(‘000)

Ownership (%)

Abdullah Al-Qadeeri

4030.03

25.19%

4030.03

20.15%

Mohammed Al-Buardi

3664.73

22.90%

3664.73

18.32%

Talal Al-Nassar

2748.88

17.18%

2748.88

13.74%

Mohammed Al-Sarhan

2015.67

12.60%

2015.67

10.08%

Treasury Shares

1600.00

10.00%

1600.00

8.00%

Sahmeen Investment

587.09

3.67%

587.09

2.94%

Farraj Al-Balawi

360.00

2.25%

360.00

1.80%

Nora Al-Sunaidi

288.00

1.80%

288.00

1.44%

Ibrahim Al-Oqeili

216.00

1.35%

216.00

1.08%

Abdulaziz Al-Bulaihis

144.00

0.90%

144.00

0.72%

Yazid Al-Buardi

86.40

0.54%

86.40

0.43%

Muteb Al-Qadeeri

86.40

0.54%

86.40

0.43%

Khalid Al-Nassar

86.40

0.54%

86.40

0.43%

Nora Al-Sahli

86.40

0.54 %

86.40

0.43%

New Shares for Qualified Investors

--

--

4000

20.00%

Total

20000

100%

21000

100%

 

Board member Azzam Al-Mufdi holds a 1.83% indirect stake in the company’s pre-IPO share capital, to become 1.47% after the offering. This is given his 5% shareholding in Sahmeen Investment, which owns 3.67% and 2.94% of the company’s pre- and post-IPO shares, respectively.

 

Additional Information

Financial Advisor & Lead Manager

Yaqeen Capital

Receiving Entities

Alinma Investment - Al Rajhi Capital - SNB Capital - Saudi Fransi Capital - Riyad Capital - ANB Capital - Alistithmar Capital - Albilad Capital - AlJazira Capital - GIB Capital - Alkhabeer Capital - SAB Invest - Sahm Capital - Derayah Financial

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.